GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Shiller PE Ratio

Genexine (XKRX:095700) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Genexine Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Genexine Shiller PE Ratio Historical Data

The historical data trend for Genexine's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Shiller PE Ratio Chart

Genexine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genexine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Genexine's Shiller PE Ratio

For the Biotechnology subindustry, Genexine's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genexine's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genexine's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genexine's Shiller PE Ratio falls into.



Genexine Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Genexine's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Genexine's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-279/118.8477*118.8477
=-279.000

Current CPI (Mar. 2024) = 118.8477.

Genexine Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -66.456 99.353 -79.496
201409 -114.232 99.608 -136.296
201412 -202.241 99.098 -242.547
201503 23.349 99.720 27.828
201506 56.038 100.050 66.567
201509 -452.977 100.110 -537.761
201512 298.153 100.220 353.570
201603 -200.445 100.560 -236.898
201606 -321.861 100.790 -379.526
201609 -273.007 101.460 -319.794
201612 -533.189 101.560 -623.949
201703 -450.462 102.850 -520.529
201706 -589.839 102.610 -683.179
201709 -39.514 103.490 -45.378
201712 311.803 102.990 359.812
201803 -397.297 104.100 -453.582
201806 -160.212 104.130 -182.856
201809 -580.500 105.650 -653.016
201812 -65.378 104.350 -74.461
201903 916.730 104.490 1,042.695
201906 -749.333 104.880 -849.128
201909 -308.211 105.200 -348.196
201912 -535.238 105.120 -605.135
202003 -451.181 105.540 -508.071
202006 -227.027 104.870 -257.287
202009 796.032 106.200 890.834
202012 456.044 105.765 512.453
202103 618.577 107.357 684.784
202106 -579.781 107.579 -640.514
202109 -468.423 108.759 -511.874
202112 -940.438 109.676 -1,019.079
202203 470.578 111.806 500.217
202206 -435.375 114.083 -453.559
202209 -536.675 114.831 -555.446
202212 -1,173.650 115.200 -1,210.810
202303 -665.000 116.550 -678.112
202306 -603.000 117.140 -611.791
202309 -504.000 119.111 -502.885
202312 76.000 118.848 76.000
202403 -279.000 118.848 -279.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Genexine  (XKRX:095700) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Genexine Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Genexine's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genexine (XKRX:095700) Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines